Terms: = Cervical cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
21 results:
1. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
[TBL] [Abstract] [Full Text] [Related]
2. A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26.
Yu M; Chi X; Huang S; Wang Z; Chen J; Qian C; Han F; Cao L; Li J; Sun H; Zhou L; Li T; Wang Y; Zheng Q; Yu H; Zhang J; Xia N; Li S; Gu Y
Vaccine; 2022 Oct; 40(42):6141-6152. PubMed ID: 36117002
[TBL] [Abstract] [Full Text] [Related]
3. Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer.
Huang H; Nie CP; Liu XF; Song B; Yue JH; Xu JX; He J; Li K; Feng YL; Wan T; Zheng M; Zhang YN; Ye WJ; Li JD; Li YF; Li JY; Cao XP; Liu ZM; Zhang XS; Liu Q; Zhang X; Liu JH; Li J
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35727633
[TBL] [Abstract] [Full Text] [Related]
4. Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response.
Shi F; Su J; Wang J; Liu Z; Wang T
Mol Cell Biochem; 2021 Feb; 476(2):1015-1024. PubMed ID: 33141310
[TBL] [Abstract] [Full Text] [Related]
5. Association of homozygous variants of STING1 with outcome in human cervical cancer.
Lubbers JM; Koopman B; de Klerk-Sluis JM; van Rooij N; Plat A; Pijper H; Koopman T; van Hemel BM; Hollema H; Wisman B; Nijman HW; de Bruyn M
Cancer Sci; 2021 Jan; 112(1):61-71. PubMed ID: 33040406
[TBL] [Abstract] [Full Text] [Related]
6. cancer cell selective probe by mimicking EGCG.
Kumazoe M; Hiroi S; Tanimoto Y; Miyakawa J; Yamanouchi M; Suemasu Y; Yoshitomi R; Murata M; Fujimura Y; Takahashi T; Tanaka H; Tachibana H
Biochem Biophys Res Commun; 2020 May; 525(4):974-981. PubMed ID: 32173528
[TBL] [Abstract] [Full Text] [Related]
7. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
Rono CK; Darkwa J; Meyer D; Makhubela BCE
Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
[TBL] [Abstract] [Full Text] [Related]
8. cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells.
Shaikh MH; Bortnik V; McMillan NA; Idris A
Microb Pathog; 2019 Jul; 132():162-165. PubMed ID: 31054871
[TBL] [Abstract] [Full Text] [Related]
9. Propranolol selectively inhibits cervical cancer cell growth by suppressing the cgmp/PKG pathway.
Gong L; Lei Y; Tan X; Dong Y; Luo Z; Zhang D; Han S
Biomed Pharmacother; 2019 Mar; 111():1243-1248. PubMed ID: 30841438
[TBL] [Abstract] [Full Text] [Related]
10. Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients.
McCormack SE; Cruz CRY; Wright KE; Powell AB; Lang H; Trimble C; Keller MD; Fuchs E; Bollard CM
Cytotherapy; 2018 Mar; 20(3):385-393. PubMed ID: 29331266
[TBL] [Abstract] [Full Text] [Related]
11. TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients.
Zom GG; Welters MJ; Loof NM; Goedemans R; Lougheed S; Valentijn RR; Zandvliet ML; Meeuwenoord NJ; Melief CJ; de Gruijl TD; Van der Marel GA; Filippov DV; Ossendorp F; Van der Burg SH
Oncotarget; 2016 Oct; 7(41):67087-67100. PubMed ID: 27564262
[TBL] [Abstract] [Full Text] [Related]
12. New bimetallic palladium(ii) and platinum(ii) complexes: studies of the nucleophilic substitution reactions, interactions with CT-DNA, bovine serum albumin and cytotoxic activity.
Jovanović S; Obrenčević K; Bugarčić ŽD; Popović I; Žakula J; Petrović B
Dalton Trans; 2016 Aug; 45(31):12444-57. PubMed ID: 27431616
[TBL] [Abstract] [Full Text] [Related]
13. Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.
Horikawa N; Baba T; Matsumura N; Murakami R; Abiko K; Hamanishi J; Yamaguchi K; Koshiyama M; Yoshioka Y; Konishi I
BMC Cancer; 2015 Oct; 15():739. PubMed ID: 26482555
[TBL] [Abstract] [Full Text] [Related]
14. Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells.
Uzawa K; Kasamatsu A; Baba T; Usukura K; Saito Y; Sakuma K; Iyoda M; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H
Cancer Med; 2013 Feb; 2(1):40-9. PubMed ID: 24133626
[TBL] [Abstract] [Full Text] [Related]
15. A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection.
Demurtas OC; Massa S; Ferrante P; Venuti A; Franconi R; Giuliano G
PLoS One; 2013; 8(4):e61473. PubMed ID: 23626690
[TBL] [Abstract] [Full Text] [Related]
16. Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol.
Rutella S; Iudicone P; Bonanno G; Fioravanti D; Procoli A; Lavorino C; Foddai ML; Lorusso D; Martinelli E; Vacca M; Ipsevich F; Nuti M; Scambia G; Pierelli L
Cytotherapy; 2012 Aug; 14(7):841-50. PubMed ID: 22563888
[TBL] [Abstract] [Full Text] [Related]
17. Selective guanosine binding and cytotoxicity of a benzimidazole derived dinickel complex.
Chen Z; Wang X; Zhu Y; Li Y; Guo Z
J Inorg Biochem; 2007 Nov; 101(11-12):1894-902. PubMed ID: 17540448
[TBL] [Abstract] [Full Text] [Related]
18. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract] [Full Text] [Related]
19. Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model.
Welters MJ; Filippov DV; van den Eeden SJ; Franken KL; Nouta J; Valentijn AR; van der Marel GA; Overkleeft HS; Lipford G; Offringa R; Melief CJ; van Boom JH; van der Burg SH; Drijfhout JW
Vaccine; 2004 Dec; 23(3):305-11. PubMed ID: 15530672
[TBL] [Abstract] [Full Text] [Related]
20. Cellular changes in HeLa cells and cervix cells after treatment with cyclic nucleotides.
Busse E; Zimmer G; Bartsch O; Kornhuber B
Oncology; 1993; 50(4):241-4. PubMed ID: 8388554
[TBL] [Abstract] [Full Text] [Related]
[Next]
